666848-11-9

基本信息
5-碘-5'-TBDMS-2'-脱氧胞苷
2'-脱氧-5'-O-[(叔丁基)二甲基硅烷基]-5-碘胞苷
4-氨基-1-((2R,4S,5R)-5-(((叔丁基二甲基硅烷基)氧基)甲基)-4-羟基四氢呋喃-2-基)-5-碘嘧啶-2(1H)-酮
5′-O-TBS IODO DC
5'-O-TBS 5-iodo dC
5'-TBDMS-5-Iodo-2'-dC
5'-O-TBS-5-iodo-2'-deoxycytidine
5'-O-TBDMS-5-Iodo-2'-DeoxyCytidine
5'-O-TBDMSoxy-5-iodo-2'-deoxycytidine
5'-O-TBDMS-5-Iodo-2'-DeoxyCytidine, >98%
5'-O-tert-Butylmethylsilyl-5-iodo-2'-deoxycytidine
5'-O-tert-Butylmethylsilyl-2'-deoxy-5-iodocytidine
物理化学性质
制备方法

611-53-0
![2'-脱氧-5'-O-[(叔丁基)二甲基硅烷基]-5-碘胞苷](/CAS/GIF/666848-11-9.gif)
666848-11-9
一般步骤:向5-碘-2'-脱氧胞苷(2.2 g,6.23 mmol)的无水DMF(130 mL)溶液中加入咪唑(467 mg,6.85 mmol)。将反应混合物冷却至0℃,并在5分钟内缓慢加入叔丁基二甲基甲硅烷基氯(TBDMSCl)(1.33 g,6.85 mmol)。反应混合物在室温下搅拌18小时后,减压浓缩以去除挥发物。残余物通过硅胶快速柱色谱法纯化,洗脱剂为EtOAc:MeOH(95:5至90:10),得到目标产物4-氨基-1-((2R,4S,5R)-5-(((叔丁基二甲基硅烷基)氧基)甲基)-4-羟基四氢呋喃-2-基)-5-碘嘧啶-2(1H)-酮(2.10 g,72%收率)及未反应的原料(490 mg)。产物表征数据如下:1H NMR (d6-DMSO) δ 0.11 (s, 3H, CH3), 0.12 (s, 3H, CH3), 0.89 (s, 9H, 3×CH3), 1.90 (ddd, J = 13.2, 7.7, 5.7 Hz, 1H, H-2'), 2.18 (ddd, J = 13.2, 5.7, 2.3 Hz, 1H, H-2'), 3.72 (dd, J = 11.5, 3.6 Hz, 1H, H-5'), 3.80 (dd, J = 11.5, 2.8 Hz, 1H, H-5'), 3.86-3.89 (m, 1H, H-4'), 4.14-4.18 (m, 1H, H-3'), 5.22 (d, J = 4.1 Hz, 1H, OH), 6.09 (dd, J = 7.8, 5.8 Hz, 1H, H-1'), 6.60 (br s, 1H, NH), 7.81 (br s, 1H, NH), 7.94 (s, 1H, H-6); MS (ES): m/z (百分比) (M + H)+ 468 (90%).
参考文献:
[1] Patent: EP2607369, 2015, B1. Location in patent: Paragraph 0183
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2025/05/22 | XW0266684811903 | 4-氨基-1-((2R,4S,5R)-5-(((叔丁基二甲基硅烷基)氧基)甲基)-4-羟基四氢呋喃-2-基)-5-碘嘧啶-2(1H)-酮 | 666848-11-9 | 1G | 367元 |
2025/05/22 | XW0266684811902 | 4-氨基-1-((2R,4S,5R)-5-(((叔丁基二甲基硅烷基)氧基)甲基)-4-羟基四氢呋喃-2-基)-5-碘嘧啶-2(1H)-酮 | 666848-11-9 | 250MG | 93元 |
2025/05/22 | XW0266684811901 | 4-氨基-1-((2R,4S,5R)-5-(((叔丁基二甲基硅烷基)氧基)甲基)-4-羟基四氢呋喃-2-基)-5-碘嘧啶-2(1H)-酮 | 666848-11-9 | 100MG | 40元 |